Media Summary: Prof Fengyan Jin of Jilin University, Jilin, China, outlines the issues with current criteria regarding (measurable residual disease) ... Mattia D'Agostino, MD, University of Turin, Turin, Italy, gives guidance on Sham Mailankody, MBBS, Memorial Sloan Kettering Cancer Center, New York City, NY, discusses

Multiple Myeloma Mrd Assessment - Detailed Analysis & Overview

Prof Fengyan Jin of Jilin University, Jilin, China, outlines the issues with current criteria regarding (measurable residual disease) ... Mattia D'Agostino, MD, University of Turin, Turin, Italy, gives guidance on Sham Mailankody, MBBS, Memorial Sloan Kettering Cancer Center, New York City, NY, discusses Adaptive Symposium - COMy Online 2020 An overview of sequence-based immune receptor profiling Lanny Kirsch, USA The ... Watch this patient-friendly animated video that explains the most important concepts for patients on Minimal Residual Disease ... In this video, Ola Landgren, MD, PhD, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, discusses the ...

Clinical insight on the current role of minimal residual disease Nikhil Munshi, MD, from the Dana-Farber Cancer Institute, Boston, MA, discusses the impact of new minimal residual disease ... Presented By: Juan Flores-Montero, MD, PhD Speaker Biography: Juan Flores-Montero holds a degree in Medicine (Venezuela, ... Dr. Neha Korde, from Memorial Sloan Kettering Cancer Center, discussed Minimal Residual Disease ( Earn CME: © 2020 Imedex, an HMP Company. Bruno Paiva, PhD of the University of Navarra, Pamplona, Spain gives an overview of his talk on immunophenotyping for

Bruno Paiva, PhD, University of Navarra, Pamplona, Spain, comments on the use of next-generation flow (NGF) versus ... María-Victoria Mateos, MD, PhD, of the University Hospital of Salamanca, Salamanca, Spain, states that measuring in depth the ... Frits van Rhee, MD, PhD, University of Arkansas for Medical Sciences (UAMS), Little Rock, AR, discusses the results of a study ... Graham Jackson, MBBS, FRCP, FRCPath, MD, Newcastle upon Tyne Hospitals NHS Trust, Newcastle, UK, discusses the ... Earn CME for related activities: In this webcast from the '

Photo Gallery

Multiple myeloma MRD assessment
Approach to MRD assessment in multiple myeloma when NGS is not available
Assessing MRD in multiple myeloma
The relevance of MRD assessment in the clinical management of Multiple Myeloma (MM) patients
What is Minimal Residual Disease (MRD) in myeloma?
Could MRD testing help determine whether transplant is needed?
Determining the optimal threshold to test MRD in multiple myeloma
Role of MRD Assessment in Multiple Myeloma
What impact have new minimal residual disease (MRD) assessment techniques had in myeloma?
Clinical value of measurable residual disease assessment in multiple myeloma
The Future of MRD Testing: Why It Matters for Multiple Myeloma Patients and What Comes Next
Approaching MRD in Multiple Myeloma
View Detailed Profile
Multiple myeloma MRD assessment

Multiple myeloma MRD assessment

Prof Fengyan Jin of Jilin University, Jilin, China, outlines the issues with current criteria regarding (measurable residual disease) ...

Approach to MRD assessment in multiple myeloma when NGS is not available

Approach to MRD assessment in multiple myeloma when NGS is not available

Mattia D'Agostino, MD, University of Turin, Turin, Italy, gives guidance on

Assessing MRD in multiple myeloma

Assessing MRD in multiple myeloma

Sham Mailankody, MBBS, Memorial Sloan Kettering Cancer Center, New York City, NY, discusses

The relevance of MRD assessment in the clinical management of Multiple Myeloma (MM) patients

The relevance of MRD assessment in the clinical management of Multiple Myeloma (MM) patients

Adaptive Symposium - COMy Online 2020 An overview of sequence-based immune receptor profiling Lanny Kirsch, USA The ...

What is Minimal Residual Disease (MRD) in myeloma?

What is Minimal Residual Disease (MRD) in myeloma?

Watch this patient-friendly animated video that explains the most important concepts for patients on Minimal Residual Disease ...

Could MRD testing help determine whether transplant is needed?

Could MRD testing help determine whether transplant is needed?

Could

Determining the optimal threshold to test MRD in multiple myeloma

Determining the optimal threshold to test MRD in multiple myeloma

In this video, Ola Landgren, MD, PhD, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, discusses the ...

Role of MRD Assessment in Multiple Myeloma

Role of MRD Assessment in Multiple Myeloma

Clinical insight on the current role of minimal residual disease

What impact have new minimal residual disease (MRD) assessment techniques had in myeloma?

What impact have new minimal residual disease (MRD) assessment techniques had in myeloma?

Nikhil Munshi, MD, from the Dana-Farber Cancer Institute, Boston, MA, discusses the impact of new minimal residual disease ...

Clinical value of measurable residual disease assessment in multiple myeloma

Clinical value of measurable residual disease assessment in multiple myeloma

Presented By: Juan Flores-Montero, MD, PhD Speaker Biography: Juan Flores-Montero holds a degree in Medicine (Venezuela, ...

The Future of MRD Testing: Why It Matters for Multiple Myeloma Patients and What Comes Next

The Future of MRD Testing: Why It Matters for Multiple Myeloma Patients and What Comes Next

Dr. Neha Korde, from Memorial Sloan Kettering Cancer Center, discussed Minimal Residual Disease (

Approaching MRD in Multiple Myeloma

Approaching MRD in Multiple Myeloma

Earn CME: https://www.naccme.com/oln © 2020 Imedex, an HMP Company.

The use of immunophenotyping to assess minimal residual disease (MRD) in multiple myeloma

The use of immunophenotyping to assess minimal residual disease (MRD) in multiple myeloma

Bruno Paiva, PhD of the University of Navarra, Pamplona, Spain gives an overview of his talk on immunophenotyping for

MRD as a response assessment in elderly multiple myeloma

MRD as a response assessment in elderly multiple myeloma

Measurable residual disease (

Comparing next-generation flow and next-generation sequencing for MRD assessment in myeloma

Comparing next-generation flow and next-generation sequencing for MRD assessment in myeloma

Bruno Paiva, PhD, University of Navarra, Pamplona, Spain, comments on the use of next-generation flow (NGF) versus ...

The importance of MRD assessment in Myeloma with Prof. Mateos

The importance of MRD assessment in Myeloma with Prof. Mateos

María-Victoria Mateos, MD, PhD, of the University Hospital of Salamanca, Salamanca, Spain, states that measuring in depth the ...

Serial MRD assessment as a surrogate for PFS in multiple myeloma

Serial MRD assessment as a surrogate for PFS in multiple myeloma

Frits van Rhee, MD, PhD, University of Arkansas for Medical Sciences (UAMS), Little Rock, AR, discusses the results of a study ...

What is Minimal Residual Testing in Multiple Myeloma?

What is Minimal Residual Testing in Multiple Myeloma?

How is minimal residual

Depth of MRD assessment in MM

Depth of MRD assessment in MM

Graham Jackson, MBBS, FRCP, FRCPath, MD, Newcastle upon Tyne Hospitals NHS Trust, Newcastle, UK, discusses the ...

Multiple Myeloma: Minimal Residual Disease

Multiple Myeloma: Minimal Residual Disease

Earn CME for related activities: https://www.naccme.com/oln In this webcast from the '